FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts ; volume:8 ; number:1 ; day:2 ; month:5 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (2.5.2018), 1-10, 12.2018
- Urheber
-
Garner, Evan F.
- Beteiligte Personen und Organisationen
-
Williams, Adele P.
Stafman, Laura L.
Aye, Jamie M.
Mroczek-Musulman, Elizabeth
Moore, Blake P.
Stewart, Jerry E.
Friedman, Gregory K.
Beierle, Elizabeth A.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-25263-5
- URN
-
urn:nbn:de:101:1-2018070100142915645493
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Garner, Evan F.
- Williams, Adele P.
- Stafman, Laura L.
- Aye, Jamie M.
- Mroczek-Musulman, Elizabeth
- Moore, Blake P.
- Stewart, Jerry E.
- Friedman, Gregory K.
- Beierle, Elizabeth A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts
Patient-derived xenografts as preclinical neuroblastoma models
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Molecular profiling of patient-derived breast cancer xenografts
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Patient-derived xenografts as compatible models for precision oncology
Patient-derived xenografts: a relevant preclinical model for drug development
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
Factors associated with engraftment success of patient-derived xenografts of breast cancer
Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts
Patient-derived xenografts as preclinical neuroblastoma models
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Molecular profiling of patient-derived breast cancer xenografts
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Patient-derived xenografts as compatible models for precision oncology
Patient-derived xenografts: a relevant preclinical model for drug development
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
Factors associated with engraftment success of patient-derived xenografts of breast cancer
Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts
Patient-derived xenografts as preclinical neuroblastoma models
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Molecular profiling of patient-derived breast cancer xenografts
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Patient-derived xenografts as compatible models for precision oncology
Patient-derived xenografts: a relevant preclinical model for drug development
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource